Broad repetitive transcranial magnetic stimulation (rTMS) of the precuneus in Alzheimer's disease: A rationale and study design.
Michael K Leuchter, Hanadi A Oughli, Kelly A Durbin...
https://pubmed.ncbi.nlm.nih.gov/40065917/Actively Recruiting
Led by University of California, Los Angeles · Updated on 2026-09-04
54
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are studying whether using large-coil repetitive transcranial magnetic stimulation rTMS targeting the precuneus area of the brain can be safely and effectively used to improve memory in people with Alzheimers Disease AD. This study focuses on mild to moderate AD and aims to determine if this non-invasive brain stimulation is feasible, tolerable, and shows signs of memory improvement compared to placebo. The trial also investigates changes in brain function and structure related to this treatment. Participants will receive 28 sessions of deep rTMS over 9 weeks. The treatment starts with an intensive induction phase of four sessions per day for three days, followed by weekly maintenance visits with two sessions each. Some participants will receive active rTMS targeting the precuneus, while others will receive a sham placebo version. After completing the randomized phase, those initially in the placebo group can opt for active treatment in an open-label extension. During the study, participants will undergo memory tests, brain scans, blood tests, and measurements of brain electrical activity. Caregivers will also provide information through weekly check-ins and questionnaires. Researchers will assess whether participants complete the treatment, monitor side effects, and evaluate brain and cognitive changes. The total study duration includes 9 weeks of treatment with ongoing assessments to understand the impact of rTMS on Alzheimers disease.
CONDITIONS
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD)
G
Griffin Bohman
M
Michael Leuchter, MD, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of California, Los Angeles
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Active deep rTMS (precuneus) | Sham deep rTMS |
|---|---|---|
| What it is | Deep repetitive transcranial magnetic stimulation targeting the precuneus using MRI navigation at 100 % motor threshold with 20 Hz frequency | Sham coil placed at the same location with matching sensations but without delivering active stimulation |
| Role in trial | Experimental treatment arm | Placebo comparator arm |
| Primary use | Test whether rTMS over the precuneus can be safely delivered and completed over 9 weeks in participants with mild to moderate Alzheimer’s disease | Serve as inert control to compare treatment completion rate and tolerability over 9 weeks |
| Evidence status | Clinical efficacy is under investigation; preliminary meta‑analyses show modest cognitive benefits of rTMS in mild‑to‑moderate Alzheimer’s | Not a therapeutic intervention; serves as placebo control |
| Important limitations | Evidence from prior rTMS studies is generally low‑quality with methodological variability, limiting confidence | As placebo control, it does not provide therapeutic benefit |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 9 weeks
Participants receive 28 sessions of deep rTMS or sham stimulation targeting the precuneus over 9 weeks, starting with an intensive 3-day induction phase followed by weekly maintenance visits.
3 visits for induction phase and 8 weekly maintenance visits
Duration - Varies by participant
Participants initially receiving sham stimulation are offered active rTMS treatment after the randomized phase is complete.
Visits based on treatment schedule during extension
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Michael K Leuchter, Hanadi A Oughli, Kelly A Durbin...
https://pubmed.ncbi.nlm.nih.gov/40065917/University of California, Los Angeles
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor